Prometheus Biosciences, Inc. (RXDX) financial statements (2022 and earlier)

Company profile

Business Address 9410 CARROLL PARK DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments257,254
Cash and cash equivalents257,254
Receivables1,079
Prepaid expense1,218
Other undisclosed current assets5,832
Total current assets:265,383
Noncurrent Assets
Property, plant and equipment1,447
Other undisclosed noncurrent assets971
Total noncurrent assets:2,418
TOTAL ASSETS:267,801
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,987
Accounts payable1,153
Accrued liabilities456
Employee-related liabilities5,378
Deferred revenue3,668
Disposal group, including discontinued operation193
Other undisclosed current liabilities5,594
Total current liabilities:16,442
Noncurrent Liabilities
Liabilities, other than long-term debt16,204
Deferred revenue16,204
Total noncurrent liabilities:16,204
Total liabilities:32,646
Stockholders' equity
Stockholders' equity attributable to parent235,155
Common stock4
Additional paid in capital424,492
Accumulated deficit(189,341)
Total stockholders' equity:235,155
TOTAL LIABILITIES AND EQUITY:267,801

Income statement (P&L) ($ in thousands)

12/31/2021
Revenues3,129
Gross profit:3,129
Operating expenses(90,932)
Operating loss:(87,803)
Nonoperating expense(2,392)
Interest and debt expense(554)
Net loss:(90,749)
Other undisclosed net income attributable to parent554
Net loss available to common stockholders, diluted:(90,195)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(90,749)
Comprehensive loss, net of tax, attributable to parent:(90,749)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: